Ardelyx reported $19.34M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Amgen AMGN:US $ 1.23B 197M
Ardelyx ARDX:US $ 19.34M 5.1M
Astrazeneca AZN:US 3.06B 1.03B
Biocept BIOC:US $ 10.47M 5.22M
Chimerix CMRX:US 5.63M 391K
Corcept Therapeutics CORT:US $ 37.55M 5.26M
Curis CRIS:US $ 5.67M 900K
Life Technologies LIFE:US $ 3.48M 797K
Opko Health OPK:US $ 117.54M 20.68M
Tg Therapeutics TGTX:US $ 20.61M 11.8M
United Therapeutics UTHR:US $ 79M 47.9M
Xoma XOMA:US $ 5.12M 422K